Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More
Xconomy
MAY 10, 2019
An April report from Evaluate Pharma predicted sales of orphan drugs to rise 12 percent a year between now and 2024, when they will account for an estimated 20 percent of worldwide prescription drug sales. The field has gotten so competitive that multiple products are on the market for some diseases.
97 
Let's personalize your content